BIOREM Inc.
BRM.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,978.38% | -78.77% | -92.41% | 552.80% | -3.53% |
| Total Depreciation and Amortization | -15.80% | -6.30% | -26.14% | 147.53% | 0.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 361.39% | 112.04% | -167.92% | 370.17% | 1.39% |
| Change in Net Operating Assets | -158.55% | 407.22% | -1,003.28% | 94.97% | -168.40% |
| Cash from Operations | -129.52% | 370.99% | -153.21% | 263.61% | -144.75% |
| Capital Expenditure | -184.36% | -1,610.81% | -- | 100.00% | 99.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -184.36% | -1,610.81% | -- | 100.00% | 99.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 9.22% | -59.03% | 35.75% | -18.65% | 25.34% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.85% | -836.41% | 113.18% | -18.99% | 26.41% |
| Foreign Exchange rate Adjustments | -1,561.33% | 97.34% | -180.43% | 553.17% | 211.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -145.98% | 307.55% | -159.61% | 269.24% | -154.52% |